Compare Mutual Funds
Pros | - | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Among most bought funds within the category. | ||
Cons | - | - |
INDMoney rank | - | 2/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 4 Years 5 Months | 7 Years 10 Months | ||
Fund AUM | ₹222 Cr | ₹6801 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.47% | 1.04% | ||
Exit Load | 0.5% | 1% | ||
Benchmark Index | Nifty Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 44 | 43 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 4 | 2 | ||
Top 3 Sectors |
|
| ||
Equity % | 98.21% | 97.98% | ||
Debt % | - | - | ||
P/E | 41.1 | 32.15 | ||
P/B | 5.68 | 3.94 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -6.12% | -4.39% | ||
3-Month Return | -6.32% | -8.26% | ||
6-Month Return | -7.08% | -6.8% | ||
1-Year Return | -3.32% | 2.14% | ||
3-Year Return | 20.32% | 26.27% | ||
5-Year Return | - | 16.91% |
Sharpe | 0.83 | 1.13 | ||
Alpha | -1.56 | 2.05 | ||
Beta | 0.92 | 0.95 | ||
Standard Deviation | 16.41 | 16.39 | ||
Information Ratio | -0.69 | 0.42 |
Description | ITI Pharma and Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Rohan Korde, Dhimant Shah | Dharmesh Kakkad, Sharmila D’mello |

